Digital Marketing Competency Report Reveals 2022 Ranking of Biopharma Brands Based on Digital Patient Experiences

Trinity Life Sciences, a leader in global life sciences commercialization solutions, released its second annual TGaS Digital Marketing Competency Report assessing 160+ biopharma brands through the lens of digital patient experiences. The novel study evaluates the brands across five categories and 60 unique metrics to understand each one’s digital marketing presence.

The Digital Marketing Competency Report ranks each individual brand on a scale ranging from Transformational to Novice. It also examines the influence of spend, time in market, therapeutic areas and impact on individual channels to give organizations unrivaled insight into not only their own assessment, but also their competitors.

“The rapid evolution in omnichannel execution and patient centricity has led to a hyperfocus on how brands invest and measure digital marketing effectiveness,” said Jerry Luciano, VP of Omnichannel Marketing, at TGaS Advisors, a division of Trinity Life Sciences. “Now more than ever, it is critical for organizations to understand what they should be doing to optimize the digital patient experience. This ranking helps put in context where some of the world’s most important brands stand and provides insight into how some of the top brands are excelling.”

Brands that topped the 2022 Digital Marketing Competency Report’s list include:

• Biohaven’s Nurtec
• AbbVie’s Ubrelvy
• Horizon’s Tepezza
• Sprout’s Addyi
• Amgen’s Aimovig

Learn what sets some brands apart from others. To download the summary of the report with the ranking of all 160+ brands, please visit TrinityLifeSciences.com or click here. The full report, including in-depth channel analysis and trends is available to members of the TGaS Omnichannel Marketing network.

About Trinity Life Sciences

Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With 25 years of experience, Trinity is committed to revolutionizing the commercial model by providing exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221115005509/en/